ArticleACS infectious diseases2019

High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.

Nina M Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.